RxDoctor Payments Data

Christian Schadt, APRN

Family · Daytona Beach, FLNPI 1568077501

Payments from drug & device makers

$1,894in general payments, 2019–2025

Across 96 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$603
  • GSK$304
  • Boehringer Ingelheim$298
  • Amgen$147
  • Regeneron Healthcare Solutions, Inc.$91
  • Takeda Pharmaceuticals U.S.A., Inc.$62
  • plus $389 from 10 others

What the payments were for

  • Food & beverage$1,894100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,894 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$16,772
Medicare patients
47
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter89$73,881
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$17,492
Ventolin HfaAlbuterol Sulfate24$1,467
Albuterol Sulfate HfaAlbuterol Sulfate45$1,308
Wixela InhubFluticasone Propion/Salmeterol11$863
Fluticasone Propionate12$221
Azithromycin15$105
Levofloxacin16$105
Prednisone35$84

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$304$73,88189 claims
AstraZenecaBreztri Aerosphere$603$17,49217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.

Other family in Daytona Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →